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Abstract The effect of hyperthyroidism on fatty acid oxidation 
and on carnitine-acylcarnitine translocase activity in rat heart 
mitochondria has been studied. The rates of palmitoylcamitine 
supported respiration as well as the carnitine-pahnitoylcamitine 
exchange reaction were both stimulated (approx. 36%) in heart 
mitochondria from hyperthyroid rats. Kinetic analysis of the 
carnitine-carnitine exchange reaction showed that thyroid 
hormone affects the V,,,,, of this process, while having no effect 
on the K,,, values. The level of cardiolipin was significantly higher 
(approx. 40%) in heart mitoplasts from hyperthyroid rats than 
from the control rats. It can be concluded that thyroid hormones 
produce a stimulation of heart mitochondrial carnitine translo- 
case activity and that the basis of this effect is likely an increase 
in the cardiolipin content. 
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1. Introduction 
Thyroid hormones are known to play an important role in 
the regulation of cardiac function. Mitochondria are consid- 
ered possible subcellular loci of thyroid hormone action in 
view of their crucial role in the regulation of energy produc- 
tion. Long-chain fatty acids represent, together with pyruvate, 
the major substrate for energy production in the normal 
working heart [l]. Fatty acid oxidation rate is proportional 
to the thyroid state [2]. The major site of control of fatty acyl- 
CoA oxidation is the mechanism that transports cytoplasmic 
fatty acyl-CoA to the fatty acyl-CoA dehydrogenase in the 
mitochondrial matrix adjacent to the electron transport chain. 
Carnitine is an absolute requirement for the transport of ac- 
tivated long chain acyl units (fatty acyl-CoA) into mitochon- 
dria [3]. The inner mitochondrial membrane contains a spe- 
cific protein system for the transport of carnitine and 
acylcarnitine known as carnitine translocase [&6]. This trans- 
locase exchanges cytosolic acylcarnitine or free carnitine for 
carnitine in the mitochondrial matrix. The properties of this 
carrier system have been investigated in intact mitochondria 
[5,7]. The carnitine carrier has been isolated and its activity 
reconstituted in artificial membranes as liposomes [8]. An es- 
sential requirement of cardiolipin for mitochondrial carnitine 
acylcarnitine translocase activity has been demonstrated [8,9]. 
We have recently reported that the activity of several anion 
carrier proteins is stimulated in heart mitochondria isolated 
from hyperthyroid rats [l&12]. Changes in the mitochondrial 
cardiolipin content have been considered as a possible factor 
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responsible for this effect by thyroid hormone. In addition, it 
has been recently reported that mitochondrial cardiolipin bio- 
synthesis is under thyroid hormone regulation [13,14]. 
To date, there has been no report assessing heart mitochon- 
drial carnitine-acylcarnitine translocase activity relative to the 
hyperthyroid state. In this paper the effect of hyperthyroidism 
on fatty acids oxidation, camitine-acylcarnitine translocase 
activity and phospholipid composition in rat heart mitochon- 
dria was examined. 
2. Materials and methods 
Male Wistar rats (180-200 g) were made hyperthyroid using 3,3’,5- 
triiodo-L-thyronine (30 kg/100 body wt), injected intraperitoneally 
with a single daily injection for 5 consecutive days [lo]. Rat heart 
mitochondria were prepared as described previously [1.5]. 
Rat heart mitoplasts were prepared as described in 1161. 
Carnitine-acylcarnitine translocase activity was determined as de- 
scribed in [17]. Freshly isolated mitochondria were loaded with 2 
mM l-[methyl-14C]carnitine, essentially as described by Pande and 
Parvin [6]. Efflux of radiolabeled carnitine was initiated at 0°C by 
addition of [14C]carnitine-loaded mitochondria (approx. 0.5 mg pro- 
tein) to 0.5 ml 200 mM mannitol and 50 mM Tris-HCl (pH 7.4) 
containing unlabeled carnitine or palmitoylcarnitine. The exchange 
reaction was stopped by the addition of 1 mM mersalyl followed by 
rapid centrifugation of the mitochondrial suspension and measure- 
ment of radioactivity in the supematant and pellet. Mitochondrial 
inhibitors rotenone, oligomycin and antimycin were included through- 
out the loading and assay procedure to dissociate carnitine-acylcami- 
tine transport from electron transport and oxidative phosphorylation. 
Rates of exchange were calculated as described by Pande and Parvin 
[61. 
Phospholipids were analysed by HPLC as described in [18]. 
Protein concentration was measured by the usual biuret method. 
3. Results and discussion 
Table 1 presents the results of experiments on fatty acid 
oxidation in heart mitochondria isolated from control and 
hyperthyroid rats. Rates of phosphorylating oxygen consump- 
tion with palmitoylcarnitine were significantly higher (approx. 
35%) in mitochondria from hyperthyroid rats compared to the 
values obtained with normal rats. Similar results were ob- 
tained when palmitoylcarnitine was replaced by other fatty 
acid respiratory substrates such as palmitoyl-CoA plus carni- 
tine or acetyl+carnitine (results not presented). 
Palmitoylcarnitine-carnitine exchange represents the physio- 
logical expression of carnitine translocase activity in the path- 
way to oxidation of fatty acids. Since palmitoylcarnitine-sup- 
ported respiration is increased in mitochondria from 
hyperthyroid rats (see Table l), it seemed possible that in- 
creased rates of exchange of extramitochondrial palmitoylcar- 
nitine for matrix carnitine may be responsible for the stimula- 
tion of palmitoylcarnitine oxidation. To assess this, the 
activity of carnitine-palmitoylcarnitine exchange was meas- 
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Table 1 
Rates of palmitoylcarnitine supported respiration in heart mitochon- 
dria isolated from control and hyperthyroid rats 
Animals Rates of 02 consumption 
(ng atoms O/min per mg protein) 
State 3 State 4 RCR 
Control 284 + 32 35+4.2 8.1 
Hyperthyroid 383 + 38” 44+5.1 8.7 
Rates of mitochondrial respiration were measured polarographically 
with a Clark-type oxygen electrode. The respiration medium consisted 
of 120 mM KCl, 20 mM Na-HEPES, 1 mM MgCls, 1 mM EDTA, % 
mM phosphate. Final pH 7.4. When a steady state of oxygen con- 
sumption was obtained, 0.01 mM palmitoylcarnitine plus 2 mM ma- 
late were added and 1 min later respiration was stimulated by adding 
1 mM ADP. Each value represents the mean f S.E.M. for four sepa- 
rate experiments with three rats for each group. 
aP < 0.01 vs. control. 
0.6 r -o- Control 
0.4 
0.2 
0 
ured in mitochondria from control and hyperthyroid rats. 
Due to the membrane-active properties of the palmitoylcarni- 
tine micelles, palmitoylcarnitine exchange was measured at 
palmitoylcarnitine concentration below 20 FM. As shown in 
Fig. 1, rates of carnitine-palmitoylcarnitine exchange were sig- 
nificantly higher, at all external palmitoylcarnitine concentra- 
tions used, in heart mitochondria from hyperthyroid rats com- 
pared to the values of mitochondria from normal rats. 
4 8 12 16 20 
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Fig. 1. Rates of carnitine-palmitoylcarnitine exchange in heart mito- ^ 
chondria isolated from control and hyperthyroid rats. Mttochondrta 
loaded with [‘*C]carnitine were added to a medium containing vary- 
ing amounts of palmitoylcarnitine to initiate the exchange. Values 
are expressed as mean f S.E.M. for four separate experiments with 
three rats for each group. 
The kinetic parameters of the carnitine translocase in mito- 
chondria isolated from control and hyperthyroid rats were 
determined by studying the dependence on substrate concen- 
tration of the rate of carnitine efflux by carnitine preloaded 
mitochondria. The data reported in Table 2 indicate that the 
maximal velocity of carnitine transport was significantly en- 
hanced (around 38%) in mitochondria from hyperthyroid rats 
compared with that obtained in mitochondria from control 
rats, while the K, value was unaffected. 
It has been reported that cardiolipin, a phospholipid almost 
exclusively located in the inner mitochondrial membrane [19], 
is specifically required for optimal functioning of the isolated 
carnitine-acylcarnitine translocase reconstituted in liposomes 
[8,9]. Moreover, in intact mitochondria of rat liver and heart, 
the carnitine translocase activity was markedly inhibited by 
micromolar concentrations of doxorubicin [9], a specific car- 
diolipin binding agent [20]. Thus, changes in mitochondrial 
cardiolipin content may affect the carnitine translocase activ- 
ity in situ. Since the carnitine translocase protein is located at 
the level of the inner mitochondrial membrane, the phospho- 
lipid composition of mitoplasts isolated from normal and hy- 
perthyroid rats was analysed. The results reported in Table 3 
demonstrate that the content of cardiolipin was significantly 
increased (around 40%) in mitoplasts from hyperthyroid rats, 
while there was no substantial change in the content of other 
phospholipid species. These changes in mitochondrial cardio- 
lipin level are quantitatively associated with parallel changes 
in the rates of palmitoylcarnitine-supported respiration (Table 
1) and in the activity of carnitine-acylcarnitine exchange (Fig. 
1 and Table 2). This suggests that the observed stimulation of 
carnitine translocase in mitochondria from hyperthyroid rats 
may be mainly ascribed to an increase in the cardiolipin con- 
tent. Similarly to the carnitine translocase, other mitochon- 
drial anion carrier systems have been shown to be stimulated 
by thyroid hormones such as the ADPlATP carrier [21], pyr- 
uvate [lo], citrate [l l] and phosphate [12] translocators. Very 
recently, we have also reported stimulation of heart mitochon- 
drial cytochrome oxidase activity by thyroid hormones [22]. 
All these mitochondrial inner membrane transporters and en- 
zymes require cardiolipin for their optimal functioning [23]. 
Therefore, a unified mechanism responsible for thyroid hor- 
mone induced stimulation of all these membrane-associated 
transport systems and cytochrome oxidase activity can be 
postulated. This view appears particularly interesting in the 
light of recent reports which demonstrate enhancement of 
mitochondrial cardiolipin biosynthesis in animals treated 
with thyroid hormones [13,14]. 
Fatty acid oxidation provides a prime source of energy in 
heart tissue. The carnitine-acylcarnitine carrier may play a 
Table 2 
Kinetic parameters of carnitine-carnitine exchange in mitochondria 
isolated from control and hyperthyroid rats 
Animals K, (mM) V,, (nmol/min per mg protein) 
Control 1.74+0.21 1.25+0.18 
Hyperthyroid 1.66f0.34 1.72f0.22” 
The Km and V,,, values were calculated from double-reciprocal plots 
of the rates of intramitochondrial [“Clcarnitine efflux versus external 
added carnitine (ranging from 0.5 to 20 mM). Each value represents 
the mean + S.E.M. obtained for four separate experiments with three 
rats for each group. 
Table 3 
Phospholipid composition in heart mitoplasts isolated from normal 
and hyperthyroid rats 
Phospholipid Distribution (mol%) 
Control Hyperthyroid 
Cardiolipin 22.222.1 30.8 f 3.5” 
Phosphatidylethanolamine 35.8k2.7 31.6f 3.2 
Phosphatidylcholine 40.2 f 2.8 36.2 f 3.6 
Phosphatidylinositol 0.4 f 0.07 0.4 + 0.06 
&P < 0.001 vs. control. 
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central role, in addition to carnitine acyltransferases enzymes, 
in the regulation of heart energy metabolism by facilitating 
the entry of fatty acids through the mitochondrial inner mem- 
branes. Therefore, the observed stimulation of this translocase 
by thyroid hormones, may account, in addition to other fac- 
tors, for the enhanced cardiac mitochondrial oxidative capac- 
ity, typical of the hyperthyroid state. 
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